(Alliance News) - GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new single-vial, fully liquid presentation.

GSK's liquid meningitis vaccine Menveo has been approved by EU regulators, paving the way for a simpler vaccination process ...

London open The FTSE 100 is expected to open 14 points higher on Wednesday, having closed down 0.4% on Tuesday at 8,258.61.

Report Ocean has published a new report on the Sleep Disorder Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

The FDA accepts GSK's BLA seeking approval of Blenrep combinations for treating relapsed/refractory multiple myeloma. A decision is due on July 23, 2025.

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...

The brain drug developer is letting go of around 41 of its 238 employees, in a move the company says will help “align resources” with its strategic priorities.

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the ...

Worldline, Alstom, Teleperformance... ont connu des chutes boursières inédites, conséquence de la financiarisation de ...

London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License ...